Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease
Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s ...
The Debrief16m
Physicists Create Time Quasicrystal that Defies Common Perceptions of Time and Motion
Physicists have just created the first-ever time quasicrystal, a new phase of matter that appears to defy concepts of time ...